ChemoCentryx's Lead Drug Meets Phase II Objective; Novartis Reports Results of Trial Evaluating Use of Afinitor Print E-mail
By William Kent   
Friday, 12 December 2014 18:58
Below is a look at some of
the headlines for companies that made news in the healthcare sector on December 12, 2014.
Read more...
 
Nektar Offers Data on Sub-Study of

Error. Page cannot be displayed. Please contact your service provider for more details. (31)

Phase 3 BEACON Study of NKTR-102; NewLink Genetics Sinks On Temporary Halt Of Ebola Trial
Print E-mail
By Josh Gee   
Thursday, 11 December 2014 19:03
Below is a look at some of the headlines for companies that made news in the healthcare sector on December 11, 2014.
Read more...
 
Phase 3 PREVAIL Trial Named Clinical Advance of the Year by SCRIP; Teva Announces Launch of First Generic Celebrex® Capsules Print E-mail
By Marilyn Mullen   
Wednesday, 10 December 2014 19:47
Below is a look at some of the headlines for companies that made news in the healthcare sector on December 10, 2014.
Read more...
 
Jazz Pharma and Concert Pharma Provide JZP-386 Update; ARIAD Reports Follow-up Data from Phase 1, PACE Trials of Ponatinib Print E-mail
By William Kent   
Tuesday, 09 December 2014 20:13
Below is a look at some of the headlines for companies that made news in the healthcare sector on December 9, 2014.
Read more...
 
CEL-SCI Expands Its Pivotal Phase III Immunotherapy Cancer Trial; Karyopharm to Present Clinical Data Update for Selinexor (KPT-330) Print E-mail
By Josh Gee   
Monday, 08 December 2014 19:43
Below is a look at some of the headlines for companies that made news in the healthcare sector on December 8, 2014.
Read more...
 
Apricus Announces First Patient Enrolled in Phase 2a Clinical Trial for RayVa(TM); Keryx Announces Issuance of a New U.S. Patent for Auryxia(TM) Print E-mail
By Josh Gee   
Thursday, 04 December 2014 16:04
Below is a look at some of the headlines for companies that made news in the healthcare sector on December 4, 2014.
Read more...
 
CytRx Receives Written FDA Communication Regarding Partial Clinical Hold for Aldoxorubicin; Oncotype DX Predicts Outcomes In Prostate Cancer Patients Print E-mail
By Marilyn Mullen   
Wednesday, 03 December 2014 20:13
Below is a look at some of the headlines for companies that made news in the healthcare sector on December 3, 2014.
Read more...
 
Prothena Reports Initiation of NEOD001 Global Phase 3; Keryx Offers Phase 2 Trial Results for Auryxia Print E-mail
By William Kent   
Tuesday, 02 December 2014 19:49
Below is a look at some of the headlines for companies that made news in the healthcare sector on December 2, 2014.
Read more...
 
OncoMed Begins Patient Dosing In Phase 2 Clinical Trial Of Tarextumab; MWV's MEMS System Chosen For Trials Of HIV-Prevention Medication Print E-mail
By Marilyn Mullen   
Monday, 01 December 2014 19:37
Below is a look at some of the headlines for companies that made news in the healthcare sector on December 1, 2014.
Read more...
 
FDA Orders New Label For Biogen Idec's MS Drug; Exact Sciences Announces Final Payment Decision for Cologuard® Print E-mail
By William Kent   
Tuesday, 25 November 2014 20:39
Below is a look at some of the headlines for companies that made news in the healthcare sector on November 25, 2014.
Read more...
 
<< Start < Prev 11 12 13 14 15 16 17 18 19 20 Next > End >>

Page 18 of 369
BMR:1